http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007137838-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9df90d7822cc480ce12c480f4089e229 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
| filingDate | 2005-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7db89ec83903c6dd35d0ada8d56ccc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2adbc7fcf2ae72ddfaa5d91d88f3c8d |
| publicationDate | 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007137838-A |
| titleOfInvention | Pharmaceuticals containing oxoline compounds as active ingredients |
| abstract | The purpose of the present invention is to elucidate the physiological characteristics of certain oxoline compounds and to develop new and useful applications. SOLUTION: General formula Or (Wherein R 1 is a hydrocarbon group or a substituted hydrocarbon group, R 2 and R 3 are a hydrogen atom, a hydrocarbon group or a substituted hydrocarbon group, and R 4 and R 5 are a hydroxyl group, an alkyl group, an alkoxy group or an aryl group, respectively. Base) It is set as the pharmaceutical which contains the oxoline compound represented by these as an active ingredient. [Selection figure] None |
| priorityDate | 2005-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.